LoginRegister
    Trump administration scraps key plan to reduce US drug pricesTrump administration scraps key plan to reduce US drug prices
    CDSCO Committee turns down Novartis FDC drug including Vildagliptin, Metformin, GlimepirideCDSCO Committee turns down Novartis FDC drug including Vildagliptin, Metformin, Glimepiride
    Amazon Alexa to now offer medical advice for migraines, flu in UKAmazon Alexa to now offer medical advice for migraines, flu in UK
    HealthAssure raises over Rs 17 crore in Series A funding led by Blume VenturesHealthAssure raises over Rs 17 crore in Series A funding led by Blume Ventures
    Torrent Pharma, Glenmark enter agreement to market Remogliflozin under trademark Zucator in IndiaTorrent Pharma, Glenmark enter agreement to market Remogliflozin under trademark Zucator in India
    Export-focused domestic pharma companies need to step up regulatory compliance: ReportExport-focused domestic pharma companies need to step up regulatory compliance: Report
    Top China medical device manufacturer risks getting too pricey: ReportTop China medical device manufacturer risks getting too pricey: Report
    Chemist shop owner, associate held for selling psychotropic drugs to minors at inflated ratesChemist shop owner, associate held for selling psychotropic drugs to minors at inflated rates
    Fortis ​Healthcare divests 28 percent stake in Mauritius-based Medical and Surgical CentreFortis ​Healthcare divests 28 percent stake in Mauritius-based Medical and Surgical Centre
    Dr Reddys launches OTC brand equivalent of Mucinex D ER tablets to treat phlegmDr Reddys launches OTC brand equivalent of Mucinex D ER tablets to treat phlegm
    Lupin unveils generic Imatinib Mesylate tablets to treat types of cancerLupin unveils generic Imatinib Mesylate tablets to treat types of cancer
    Scaling down customs duty of medical devices in Union budget to increase healthcare affordability, says MTalScaling down customs duty of medical devices in Union budget to increase healthcare affordability,...
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X